KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Treasury Shares (2016 - 2026)

Encompass Health (EHC) has disclosed Treasury Shares for 17 consecutive years, with $722.5 million as the latest value for Q4 2025.

  • For Q4 2025, Treasury Shares rose 25.02% year-over-year to $722.5 million; the TTM value through Dec 2025 reached $722.5 million, up 25.02%, while the annual FY2025 figure was $722.5 million, 25.02% up from the prior year.
  • Treasury Shares hit $700000.0 in Q1 2026 for Encompass Health, down from $1.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $15.3 million in Q4 2024 and bottomed at $100000.0 in Q3 2024.
  • Average Treasury Shares over 3 years is $2.4 million, with a median of $450000.0 recorded in 2025.
  • Year-over-year, Treasury Shares grew 1.96% in 2023 and then increased 25.02% in 2025.
  • Encompass Health's Treasury Shares stood at $521.2 million in 2021, then rose by 2.97% to $536.7 million in 2022, then grew by 1.96% to $547.2 million in 2023, then increased by 5.61% to $577.9 million in 2024, then rose by 25.02% to $722.5 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $722.5 million, $577.9 million, and $547.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.